Medicalgorithmics S.A. — Board/Management Information 2021

Jun 15, 2021

Brandon von Tobel, MD, MBE

Growth-oriented and budget-minded executive with physician-level industry knowledge and a venture capital background who has a proven record of streamlining businesses while growing revenue and a history of building successful national and international sales networks while navigating the uncertain realm of the global and US healthcare environment. Agile, strategic leader who has executed multi-million dollar budgetary decisions to maximize ROI on operations in marketing, sales, finance, analytics, & business development in order to exceed profit/sales goals. Successfully raised over \$200 million in debt and equity financings & closed on nearly \$1 billion in acquisitions and exits.

EXPERIENCE

D-Ink Inc.

CEO & Founder

New York, New York

July 2017-present

Financial and operational consulting with startups, healthcare practices, and established companies in need of executive expertise, financial planning, M&A advising, commercial strategy, HR expansion, & Sales and Marketing acumen. Recent Advising Services

• · Launching and fundraising for a medical device/medication management/telemedicine app-based platform
• · Implementing CFO controls, constructional DTC plan, and website/marketing development for a B2B medical device company
• · Executed after negotiating the undisclosed SMM sale of a multi-unit Florida dental practice
• · Consulted on the acquisition and sales-force integration for a medical device company
• · Advised on the capital deployment and expansion of a multi-state manufacturing and design firm
• · Financial advisor and bank-interface on the site expansion of a NY-based charity
• Negotiated and executed the undisclosed SMM sale of statewide South Carolina medical and surgical practice

Cadit Health Inc.

CFO & COO

New York, New York September 2015-December 2018

Served as the Financial, Business Development, & Operations leader of a healthcare SanSVIT company that enables patients to find and schedule appointments with any doctor in the United States. Cadi's three revenue streams were derived from a web-based, callcenter scheduling platform: transactions within the Consumer Directories, via Pharmaceutical drug web poges, and a Shared-Savings Model with Payors & Employers.

Operations

• " Directed all activities and >90 staff members at 2 call centers (Cuore and Carenet Healthcare Services)
• Acting Chief Medical Officer
• Exceeded performance metrics (>25%) and targets with advertising agencies / pharmaceutical companies for all online campaigns
• = Developed an on-boarding lesson plan and educational guide for all new call center employees
• Manged the technological/software/information compiling to ensure the highest level of regulatory and HIPAA compliance with PHI (G .
• Actively worked with CTO to update and to streamline platform and new version releases

Business Development

• Sourced and closed >\$12MM new business across all three business segments
• · Exceeded MBO targets for the 2016-218 Sales & Business Development strategic plans for all 3 business segments
• Engaged with customers / business partners throughout the entire sales cycle from introduction through deal execution to business reviews Finance, Fundraising, & Investor Relations
  • Successfully closed the financial and legal interactions of \$11MM debt and equity financings
  • Acting Controller: managed payroll, invoices, purchase orders, taxes, compensation plans, stock options, and closing monthly books
  • · Crafted quarterly KPI-driven investor reports, minutes, and Board presentations while attending as a Board Member

ImaCor Inc.

Garden City, New York May 2009-July 2015

CFO & de facto President Served as the Operations & Financial leader of a~S20MM in annual revenue, VC-backed medical device company that designed, mamfactured, and distributed hTEE (hemodynamic transesophageal echocardiography) technology, the first and only critical care solution enabling optimization of cardiates with continuously-available, direct cardiac visualization over filme, collectively serving >25,000 patients, >4,000 hospital administrators with the best possible clinical, cost-effective outcomes.

Finance

• Successfully sourced and managed >S55MM in equity/debt financings from JJCC, Emergent Medical Partners, Bracebridge Capital, et al
• · Built quarterly/annual bottom-up financial forecast models as well as the supporting integrated cash flow model and department budgets
• Launched the FDA-cleared commercial business and helped grow the business from \$0 to >\$15MM in annual revenue
• · Served as company Secretary/Treasurer, drafting all Board presentations, quarterly/annual investor messaging, Board resolutions, approvals, minutes, and all investor communication
• Negotiated >S15MM in manufacturing >10% annual reduction in COGS of disposable probe & ultrasound system
• · Consistently performed all comptroller activities to hit a +/- 5% bulgetary target focused on efficiency, effectiveness, and cost savings:
  • · Managed all sales inventory, inputted and paid all bills, and created all national and international sales invoices

Brandon von Tobel, MD, MBE

• · Maintained a highly controlled Accounts Payable, Accounts Receivable, and weekly Cash Flow model
• · Reconciled all company checking, savings, international currency transactions, and credit card accounts monthly

Conducted all annual financial audits & filed annual state, quarterly medical device and monthly state sales/use taxes

· Promoted from VP of Finance & Operations to CFO in November 2010

Operations

• Developed strategic annual and quartmental budgets, corresponding MBOs, and revenue build by territory
• · Managed the multiple FDA, CE Mark, Health Canada, & all scheduled audits with our in-house regulatory team
• · Negotiated >S20MM vendor contracts and capital equipment leases in order to best allocate and preserve company resources
• · Managed day-to-day operations of the headquarter office of 20 employees with 5 direct reports
• Co-led all BD activities, including meeting with vendors, customers, investors, and manufacturing partners
• · Worked directly with all department heads to develop policies, procedures, and strategies that enhanced the company mission
• " Drove KPI performance metrics for the company in the form of high level dashboards
• Co-managed the extensive global intellectual property portfolio and worked directly with counsel to strational filings

Sales & Marketing

• Launched international distribution, including >S20MM in total sales to Australia, Turkey, Romania, Italy, Saudi Arabia, & Egypt
• Built a detailed market model and corresponding presentation to determine the of the overall critical care & OR markets
• * Developed a comprehensive economic impact presentation detailing the critical care cost savings & LOS reduction with probe utilization
• " Led Grand Rounds Lectures and Presentations at >40 hospitals worldwide
• * Presented at multiple international traumant, critical care, & CT surgical conferences, e.g. ATS, STS, ISHLT, ESICM, & ISICEM
• · Participated in all US and OUS weekly sales meetings, delivering annually the "State of the Company" address
• · Managed the west coast launch, sales team education, and install of new hospital customers, e.g. Stanford, USC-Keck, & Cedars-Sinai
• · Drafted and or edited all sales and markets, including leases, company brochure, monthly newsletter, website design and layout, sales contracts, sales quotations, sales validation plans, and cost/benefit model for value analysis committees
• · Crafted quarterly and annual sales budges and commission schedules by territory for both the internal market team and field team
• · Negotiated hospital terms & condition agreements, implementation plans, shipping terms, vendor certification
• Created company-wide employee expense policy & implemented Concur's reporting software for expense tracking & reimbursement

Human Resources

• Negotiated all employment agreements, offer letters, consulting contracts, separation agreements, and exit interviews
• · Drafted the ImaCor employee handbook and evolved policies as the company grew from 8 to >50 employees
• · Managed bi-monthly payroll, calculated monthly & quarterly commissions, established the company 401k & FSA plan
• · Interviewed all potential employees and consultants and trained a full-time director of human resources
• · Conducted annual workman's compensation, product liability, healthcare, dental, vision, and general liability insurance audits

WFD Ventures LLC

Senior Associate

Valued, structured, and managed por a \$250MM healthcare-focused venture capital fund. Reported directly to the two founders, including one who was a member of J&J's MD&D Group Operating Comnittee and Chairman of J&J's Medical Devices Research and Development Council. Engaged in all aspects of including, deal generation, due diligence, valuation, portfolio management, and divestiture. Closed on \$68MM in venture debt financing.

Portfolio Company Management Experience

• · Developed go-to-market strategy for ImaCor LLC (miniaturized ultrasound probe for cardiac monitoring) with the CEO & VP of Sales · Built integrated cash flow model that was essential to determine the Company's financing requirements for the sales launch
• · Conducted weekly management calls with portfolio company CEOs and support implementation of Board directives
• Led physician surgical training for Advanced Surgical Ltd. (laparoscopic "scar-less" surgery devices, now distributed by Olympus)
• · Managed budget processes, capitalization tables, and weekly cash flow projections for 7 portfolio companies, including ImaCor LLC, AMT LLC, VisionScope LLC (miniaturized arthroscope), Avisena Inc. (revenue cycle management for healthcare providers), LinguaFlex LLC (sleep apnea device), BioScale Inc. (molecular diagnostics), and iWalk LLC (powered, robotic prostheses)
• · Aided CEOs of AMT LLC (minimally invasive obesity therapy device) & VisionScope LLC prepare for all FDA activities
• Authored business development presentations for industry consolidators
• Drafted and compiled all documentation for ImaCor LLC's 510(k) clearance process
• = Led third-party fundraising processes and closed on >S40MM for seven WFD portfolio companies

Transaction Experience

• Directed due diligence efforts for potential investments: built detailed financial, market, and return models; conducted accounting, legal, and intellectual property review; and composed and presented investment memoranda and term sheets
• Managed all legal and financial aspects of closing on \$68 MM in equity financings and \$15.5 MM in venture debt

Previous Experience

McKinsey & Company, Morgan Stanley, Merrill Lynch, Innovation Philadelphia, & Salomon Smith Barney

New York, New York 1998-2003

June 2007-May 2009

Brandon von Tobel, MD, MBE

EDUCATION

Miller School of Medicine at the University of Miami: MD Miami, Florida · Recipient of \$40,000 Annual Trustees Scholarship University of Pennsylvania School of Medicine: MBE Philadelphia, Pennsylvania Healthcare Economics at The Wharton School of Business Columbia University in the City of New York: BA, magna cum laude New York, New York Pre-medical Studies with concentrations in Economics, Biology, & French . ACTIVITIES & SKILLS Skills: Financial Modeling, Fundraising, Valuation, Due Diligence, Strategy, Human Resources, GAAP Acoounting & Bus, Dev., Regulatory Approval Process, Medical Devices, Financial Audits, Sales-team Building, Compensation Planing Languages: fluent French, advanced Spanish, conversational Italian and German

Software: Microsoft Office, G Suite, iWork, Netsuite, Salesforce, Quickbooks, Concur, MSFT Power Bl

Charity work: Active fundraiser and educator for ACE Programs for the Homeless

PUBLICATIONS & GRANTS

Gerald P. Roston and Brandon von Tobel, MD MBE. Monitoritical Care: Chapter 38 Device Development, Peter Le Roux, MD, FACS, Joshua Levine, MD, W. Kofke, MD, MBA, FCCM. Saunders, an imprint of Elsevier Inc. 2013.

C. Hinke. MD, T.R. von Tobel, MD MBE. Core Clinical Competency: Chapter 20 Osteoarthriis. A.Cristian, MD MHCM, S.Batmangelich, EdD MHPE, "Physical Medicine and Rehabilitation Patienter the Competencies" NY Demos Medical Publishers. 2014.

Arsht Ethics Research Grant. Disclosing Volume Data to Prospective Patients: Should it be part of the informed consent? University of Miami Miller School of Medicine. Brandon von Tobel, Leonidas Koniaris, MD